Yellow fever vaccine: WHO position on the use of fractional doses – June 2017 –Vaccin contre la fièvre jaune: Position de l’OMS sur l’utilisation de doses fractionnées – juin 2017

World Health Organization = Organisation mondiale de la Santé.
Wkly. epidemiol. rec; 92(25): 345-350, 2017-06-23.
Artigo em Inglês, Francês | WHOLIS | ID: who-255754

Documentos relacionados

  1. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
  2. Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen.
  3. Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.
  4. Yellow fever vaccine hesitancy and its relationship with contextual, individual, or group influences and vaccine-specific issues: a scoping review.
  5. Frequency of allergic reactions in egg allergic patients after receiving the yellow fever vaccine.
  6. Yellow fever vaccine: WHO position on the use of fractional doses ­ June 2017.
  7. Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: A pilot study.
  8. Brain-wide circuit-specific targeting of astrocytes.
  9. Reply to Adler et al.
  10. Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis.